Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents

IF 4.6 2区 医学 Q2 IMMUNOLOGY
Ruth A Purcell, L Carissa Aurelia, Robyn Esterbauer, Lilith F Allen, Katherine A Bond, Deborah A Williamson, Janine M Trevillyan, Jason A Trubiano, Jennifer J Juno, Adam K Wheatley, Miles P Davenport, Thi HO Nguyen, Katherine Kedzierska, Stephen J Kent, Kevin John Selva, Amy W Chung
{"title":"Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents","authors":"Ruth A Purcell,&nbsp;L Carissa Aurelia,&nbsp;Robyn Esterbauer,&nbsp;Lilith F Allen,&nbsp;Katherine A Bond,&nbsp;Deborah A Williamson,&nbsp;Janine M Trevillyan,&nbsp;Jason A Trubiano,&nbsp;Jennifer J Juno,&nbsp;Adam K Wheatley,&nbsp;Miles P Davenport,&nbsp;Thi HO Nguyen,&nbsp;Katherine Kedzierska,&nbsp;Stephen J Kent,&nbsp;Kevin John Selva,&nbsp;Amy W Chung","doi":"10.1002/cti2.1494","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Amino acid variations across more than 30 immunoglobulin (Ig) allotypes may introduce structural changes that influence recognition by anti-Ig detection reagents, consequently confounding interpretation of antibody responses, particularly in genetically diverse cohorts. Here, we assessed a panel of commercial monoclonal anti-IgG1 clones for capacity to universally recognise two dominant IgG1 haplotypes (G1m-1,3 and G1m1,17).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Four commercial monoclonal anti-human IgG1 clones were assessed via ELISAs and multiplex bead-based assays for their ability to bind G1m-1,3 and G1m1,17 IgG1 variants. Detection antibodies were validated against monoclonal IgG1 allotype standards and tested for capacity to recognise antigen-specific plasma IgG1 from G1m-1,3 and G1m1,17 homozygous and heterozygous SARS-CoV-2 BNT162b2 vaccinated (<i>n</i> = 28) and COVID-19 convalescent (<i>n</i> = 44) individuals. An Fc-specific <i>pan</i>-IgG detection antibody corroborated differences between hinge- and Fc-specific anti-IgG1 responses.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Hinge-specific anti-IgG1 clone 4E3 preferentially bound G1m1,17 compared to G1m-1,3 IgG1. Consequently, SARS-CoV-2 Spike-specific IgG1 levels detected in G1m1,17/G1m1,17 BNT162b2 vaccinees appeared 9- to 17-fold higher than in G1m-1,3/G1m-1,3 vaccinees. Fc-specific IgG1 and <i>pan</i>-IgG detection antibodies equivalently bound G1m-1,3 and G1m1,17 IgG1 variants, and detected comparable Spike-specific IgG1 levels between haplotypes. IgG1 responses against other human coronaviruses and influenza were similarly poorly detected by 4E3 anti-IgG1 in G1m-1,3/G1m-1,3 subjects.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Anti-IgG1 clone 4E3 confounds assessment of antibody responses in clinical cohorts owing to bias towards detection of G1m1,17 IgG1 variants. Validation of anti-Ig clones should include evaluation of binding to relevant antibody variants, particularly as the role of immunogenetics upon humoral immunity is increasingly explored in diverse populations.</p>\n </section>\n </div>","PeriodicalId":152,"journal":{"name":"Clinical & Translational Immunology","volume":"13 3","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cti2.1494","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cti2.1494","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Amino acid variations across more than 30 immunoglobulin (Ig) allotypes may introduce structural changes that influence recognition by anti-Ig detection reagents, consequently confounding interpretation of antibody responses, particularly in genetically diverse cohorts. Here, we assessed a panel of commercial monoclonal anti-IgG1 clones for capacity to universally recognise two dominant IgG1 haplotypes (G1m-1,3 and G1m1,17).

Methods

Four commercial monoclonal anti-human IgG1 clones were assessed via ELISAs and multiplex bead-based assays for their ability to bind G1m-1,3 and G1m1,17 IgG1 variants. Detection antibodies were validated against monoclonal IgG1 allotype standards and tested for capacity to recognise antigen-specific plasma IgG1 from G1m-1,3 and G1m1,17 homozygous and heterozygous SARS-CoV-2 BNT162b2 vaccinated (n = 28) and COVID-19 convalescent (n = 44) individuals. An Fc-specific pan-IgG detection antibody corroborated differences between hinge- and Fc-specific anti-IgG1 responses.

Results

Hinge-specific anti-IgG1 clone 4E3 preferentially bound G1m1,17 compared to G1m-1,3 IgG1. Consequently, SARS-CoV-2 Spike-specific IgG1 levels detected in G1m1,17/G1m1,17 BNT162b2 vaccinees appeared 9- to 17-fold higher than in G1m-1,3/G1m-1,3 vaccinees. Fc-specific IgG1 and pan-IgG detection antibodies equivalently bound G1m-1,3 and G1m1,17 IgG1 variants, and detected comparable Spike-specific IgG1 levels between haplotypes. IgG1 responses against other human coronaviruses and influenza were similarly poorly detected by 4E3 anti-IgG1 in G1m-1,3/G1m-1,3 subjects.

Conclusion

Anti-IgG1 clone 4E3 confounds assessment of antibody responses in clinical cohorts owing to bias towards detection of G1m1,17 IgG1 variants. Validation of anti-Ig clones should include evaluation of binding to relevant antibody variants, particularly as the role of immunogenetics upon humoral immunity is increasingly explored in diverse populations.

Abstract Image

免疫球蛋白 G 基因变异可通过改变与检测试剂的结合而干扰抗体水平的评估
目的 30 多种免疫球蛋白(Ig)异型中的氨基酸变异可能会引起结构变化,影响抗 Ig 检测试剂的识别,从而干扰抗体反应的解释,尤其是在基因多样化的群体中。在此,我们评估了一组商用单克隆抗 IgG1 克隆对两种显性 IgG1 单倍型(G1m-1,3 和 G1m1,17)的普遍识别能力。 方法 通过酶联免疫吸附试验(ELISAs)和基于多聚酶珠的试验评估四种商品化单克隆抗人类 IgG1 克隆与 G1m-1,3 和 G1m1,17 IgG1 变体结合的能力。检测抗体根据单克隆 IgG1 异型标准进行了验证,并测试了识别来自 G1m-1,3 和 G1m1,17 同源和杂合 SARS-CoV-2 BNT162b2 疫苗接种者(n = 28)和 COVID-19 康复者(n = 44)的抗原特异性血浆 IgG1 的能力。一种 Fc 特异性泛 IgG 检测抗体证实了铰链和 Fc 特异性抗 IgG1 反应之间的差异。 结果 与 G1m-1,3 IgG1 相比,铰链特异性抗 IgG1 克隆 4E3 更倾向于结合 G1m1,17。因此,G1m1,17/G1m1,17 BNT162b2 疫苗接种者体内检测到的 SARS-CoV-2 Spike 特异性 IgG1 水平比 G1m-1,3/G1m-1,3 疫苗接种者高 9 到 17 倍。Fc 特异性 IgG1 和泛 IgG 检测抗体能等效结合 G1m-1,3 和 G1m1,17 IgG1 变体,并能检测到单倍型之间相似的 Spike 特异性 IgG1 水平。在 G1m-1,3/G1m-1,3 受试者中,4E3 抗 IgG1 对其他人类冠状病毒和流感的 IgG1 反应同样检测不到。 结论 4E3 抗 IgG1 克隆由于偏向于检测 G1m1,17 IgG1 变体,会干扰临床队列中抗体反应的评估。抗 Ig 克隆的验证应包括评估与相关抗体变体的结合,尤其是随着免疫遗传学在不同人群中对体液免疫作用的探索日益深入。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical & Translational Immunology
Clinical & Translational Immunology Medicine-Immunology and Allergy
CiteScore
12.00
自引率
1.70%
发文量
77
审稿时长
13 weeks
期刊介绍: Clinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. The Journal covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信